Home/Filings/4/0001387131-20-010306
4//SEC Filing

Milligan John C.K. IV 4

Accession 0001387131-20-010306

CIK 0000025743other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 5:05 PM ET

Size

5.6 KB

Accession

0001387131-20-010306

Insider Transaction Report

Form 4
Period: 2020-11-24
Milligan John C.K. IV
DirectorPresident, Secretary, Director10% Owner
Transactions
  • Award

    Restricted Stock Units

    2020-11-24+360,000360,000 total
    Exercise: $0.00Common Stock (360,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in two equal installments on November 24, 2021 and November 24, 2022.

Issuer

TherapeuticsMD, Inc.

CIK 0000025743

Entity typeother

Related Parties

1
  • filerCIK 0001532230

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 5:05 PM ET
Size
5.6 KB